Phytosterol and Flavone Composition for Hyperlipidemia Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments and preventions for hyperlipidemia often focus on single components, such as phytosterols or flavones derived from bamboo leaf, but lack effective synergistic combinations to comprehensively address cholesterol and triglyceride levels, particularly in reducing cholesterol produced by the liver.
Innovation Solution
A composition combining phytosterols, flavones derived from bamboo leaf, procyanidins, and β-glucan in specific mass percentages, which synergistically lowers both dietary and liver-produced cholesterol and triglycerides, thereby effectively treating and preventing hyperlipidemia.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If single components (phytosterols or flavones) are used for treating hyperlipidemia, then the treatment is simple and easy to manufacture, but the effectiveness in reducing cholesterol and triglyceride levels is insufficient
Solution Approach 1:
The patent combines four different active components (phytosterols, flavones derived from bamboo leaf, procyanidins, and beta-glucan) into a single composite preparation. Each component targets different aspects of lipid metabolism: phytosterols inhibit cholesterol absorption, flavones reduce hepatic cholesterol synthesis, procyanidins inhibit lipid peroxidation, and beta-glucan binds bile acids. This merging of multiple mechanisms into one formulation achieves synergistic effects that overcome the limitations of single-component treatments while maintaining manufacturing feasibility through established extraction and formulation techniques.
Solution Approach 2:
The invention creates a composite medicinal preparation integrating four distinct bioactive substances with complementary mechanisms of action. This composite approach allows each component to contribute its unique pharmacological properties: phytosterols compete with cholesterol for absorption, flavones inhibit HMG-CoA reductase, procyanidins scavenge free radicals and inhibit lipid peroxidation, and beta-glucan binds bile acids in the intestine. The composite formulation achieves comprehensive lipid-lowering effects that cannot be obtained with any single component alone.
2Reliability
If multiple components are combined to achieve synergistic effects, then the treatment effectiveness improves, but the composition complexity and manufacturing difficulty increase
Solution Approach 1:
The patent divides the complex lipid-lowering task into four distinct functional segments, each handled by a specific component: (1) phytosterols for inhibiting intestinal cholesterol absorption, (2) flavones for reducing hepatic cholesterol synthesis, (3) procyanidins for inhibiting lipid peroxidation and protecting blood vessels, and (4) beta-glucan for binding bile acids and promoting excretion. This segmentation allows each component to be optimized and manufactured separately using established techniques, then combined in defined proportions to achieve synergistic effects without requiring complex formulation processes.
3Device complexity
If conventional treatments focus only on cholesterol absorption inhibition, then the mechanism is simple, but they cannot effectively reduce liver-produced cholesterol
Solution Approach 1:
The patent creates a multi-functional preparation where each component addresses multiple aspects of lipid metabolism. Phytosterols not only inhibit cholesterol absorption but also modulate bile acid metabolism. Flavones derived from bamboo leaf not only reduce hepatic cholesterol synthesis but also inhibit lipid peroxidation. Procyanidins provide antioxidant protection while influencing lipid metabolism. Beta-glucan binds bile acids and promotes their excretion, indirectly reducing cholesterol synthesis. This multi-functionality ensures comprehensive coverage of all cholesterol sources (dietary and hepatic) and lipid metabolism pathways.
Solution Approach 2:
The patent introduces beta-glucan as an intermediary substance that binds bile acids in the intestine and prevents their reabsorption. By increasing bile acid excretion, this intermediary mechanism creates a metabolic drive that reduces hepatic cholesterol pools and stimulates endogenous cholesterol synthesis inhibition. This intermediary approach complements the direct inhibition of cholesterol absorption by phytosterols and the hepatic synthesis inhibition by flavones, creating a coordinated multi-step mechanism that addresses both dietary and hepatic cholesterol sources.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination achieves significant reductions in total cholesterol and low-density lipoprotein levels, with the most effective composition lowering total cholesterol by 28% and LDL by 24%, demonstrating superior treatment effects compared to single-component approaches.
Implementation Method 1
phytosterols, phytostanols, and their esters, they can compete with cholesterol in vivo for inhibiting its absorption in small intestine
Implementation Method 2
have functions of inhibiting lipid peroxidation, dilating coronary vessels, and inhibiting myocardial infarction
Implementation Method 3
procyanidins are good oxygen free radical scavengers and lipid peroxidation inhibitor
Implementation Method 4
β-glucan is a mixed linked glucan, whose molecular structure contains three glucoside bonds, β-1,3, β-1,4, and β-1,6, in which β-glucan of barley is β-1,3/1,4-glucan, can prevent and treat cardiovascular and cerebrovascular diseases caused by hyperlipidemia
Data Source
AI summary
A composition for treatment and prevention of hyperlipidemia consists of phytosterols and phytostanols 30-50%, flavones derived from bamboo leaf 20-40%, procyanidins 10-25% and β-glucan of 5-20% by weight. Said composition demonstrates markedly therapeutic effects on preventing and treating hyperlipidemia, compared with the combinations of two or three components selected from phytosterols or phytostanols, flavones derived from bamboo leaf, procyanidins and β-glucan. When applied in supplementary nutrient foods or medicaments, the present composition can effectively lower the levels of cholesterol and triglyceride in blood, therefore can be useful for treating and preventing hyperlipidemia, cardiovascular diseases, coronary heart disease, atherosclerosis, heart disease and the like.